Immune-Onc Therapeutics
Immune-Onc Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Palo Alto, California, founded in 2016 by Charlene Liao and Guo Liang Yu. The company develops novel antibody therapeutics that target myeloid cell inhibitory receptors — with a current focus on the Leukocyte Immunoglobulin-Like Receptor subfamily B (LILRB) — to treat blood cancers, solid tumors, and autoimmune and inflammatory disease. Its clinical pipeline includes IO-108, a fully human IgG4 antagonist antibody targeting LILRB2 (ILT4) in Phase 1b/2 for solid tumors including hepatocellular carcinoma, and IO-202, a first-in-class IgG1 antibody targeting LILRB4 (ILT3) in Phase 1b for acute myeloid leukemia and chronic myelomonocytic leukemia, which holds FDA Fast Track and Orphan Drug designations. Preclinical programs include IO-312, a LILRB4-directed bispecific antibody, and IO-106 targeting LAIR1. The company has clinical collaborations with BeiGene, Regeneron, and Roche, and has raised approximately $138 million across Series A and Series B financings from investors including Northern Light Venture Capital, Vivo Capital, CLI Ventures, and the Stanford-StartX Fund. Immune-Onc is a therapeutics developer, not a software or platform company: as of this profile it publishes no public API, developer portal, OpenAPI or other machine-readable contract, no SDKs, no public GitHub organization and no /.well-known/ discovery surface — its only machine-readable documents are two Squarespace RSS feeds for its news and press-release collections. This record therefore captures the company's verified public identity, its published web properties, its clinical-trial registry presence, and the probed security posture of its public web surface.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Immune-Onc Therapeutics the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Immune-Onc Therapeutics scores 6.4/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-08-17 · rubric v0.11.0
Put this on your own site. The badge is drawn live from Immune-Onc Therapeutics's current Kin Score — paste it once and it updates itself every time the score is recomputed. It follows your visitor's light or dark setting, and it links back here so anyone who sees it can read the full breakdown.
<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/immune-onc-therapeutics/"
title="Immune-Onc Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/immune-onc-therapeutics.svg"
alt="Immune-Onc Therapeutics Kin Score — API readiness rating by API Evangelist" width="150" height="150" loading="lazy">
</a>[](https://providers.apievangelist.com/providers/immune-onc-therapeutics/)<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/immune-onc-therapeutics/"
title="Immune-Onc Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/immune-onc-therapeutics/card.svg"
alt="Immune-Onc Therapeutics Kin Score — API readiness rating by API Evangelist" width="340" height="120" loading="lazy">
</a>More shapes, themes and sizes → · Score as JSON · How badges work
How we profile Immune-Onc Therapeutics
Each block below is one kind of artifact we hold for Immune-Onc Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Immune-Onc Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 7
The organization behind the API
Scroll within the panel for all 7 ·
Other 6
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/immune-onc-therapeutics · machine-readable index on apis.io
This is an independent, third-party profile of Immune-Onc Therapeutics, published by API Evangelist. We do not operate, host, resell, or support these APIs, and we are not affiliated with or endorsed by the company unless stated above. Everything here is built from publicly available information — the company's own site, developer portal, documentation, public repositories, and the specifications it publishes for public use. Nothing is obtained by breaching a system, defeating an access control, or using credentials.
The Kin Score and Agent Readiness rating are independently calculated assessments of a company's public API artifacts, scored against a published rubric. They are not certifications, endorsements, security assessments, or audits.
Corrections, re-scores, and removal are free — no partnership or purchase required, and you do not need to justify the request. A removed company is recorded as unrated, never scored zero for having asked. Acknowledgement within one business day; removal within two.
info@apievangelist.com
·
Read the full data-sourcing policy →
On a security or compliance team? Put security in the subject line and
you will get a person, not a form — we will tell you exactly which public URLs this profile was built from.